Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease: A systematic review and meta-analysis

格尔德 医学 回流 荟萃分析 内科学 置信区间 随机对照试验 子群分析 不利影响 观察研究 质子抑制剂泵 胃肠病学 前瞻性队列研究 疾病 生活质量(医疗保健) 护理部
作者
Chengu Niu,Jing Zhang,Charoo Iyer,Hayder Saeed,Kaiwen Zhu,Ahmed Elkhapery,Patrick I. Okolo
出处
期刊:Endoscopy International Open [Georg Thieme Verlag KG]
卷期号:12 (02): E199-E210
标识
DOI:10.1055/a-2231-7136
摘要

Background and study aims Gastroesophageal reflux disease (GERD) is a widespread chronic gastrointestinal condition with an increasing worldwide prevalence. This research was a systematic review and meta-analysis evaluating the efficacy, safety, and long-term outcomes of endoscopic full-thickness plication (EFTP) for the treatment of GERD. Methods A comprehensive search of databases was conducted for studies published up to April 2023. We included randomized controlled trials (RCTs) and prospective observational studies that examined the use of EFTP in treating GERD among adult patients. We calculated pooled effect estimates using a random-effects model. Results EFTP significantly improved GERD Health-Related Quality of Life (GERD-HRQL) scores at 3-, 6-, and 12-month follow-up intervals. A considerable proportion of patients discontinued proton pump inhibitors, with cessation rates of 59% (95% confidence interval [CI]: 0.47-0.71), 68% (95% CI: 0.58-0.78), and 67% (95% CI: 0.46-0.89,) at 3, 6, and 12 months, respectively. At 3 and 6 months, 61% (95% CI: 0.54-0.68) and 66% (95% CI: 0.56-0.76) of patients experienced ≥50% improvement in GERD-HRQL scores. EFTP demonstrated a favorable safety profile, with a low rate of severe adverse events. We observed a 6.76% reduction (95% CI: -14.53-1.02) in the percentage of time with esophageal pH <4, a decrease in DeMeester scores, and fewer total reflux episodes. The average procedure time was 22.75 minutes (95% CI: 22.03-23.48). Subgroup analyses suggest that both the GERDx system and the NDO Plicator are effective and safe in treating GERD. Conclusions The findings from our study reveal that EFTP is a safe and effective treatment for GERD patients who have not responded adequately to conventional therapies. Given its minimally invasive nature, effectiveness, and limited adverse effects, EFTP emerges as a compelling alternative to conventional surgical procedures.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
墩墩完成签到,获得积分10
2秒前
fenghfly应助zzy采纳,获得30
7秒前
8秒前
丁晓格完成签到 ,获得积分10
10秒前
大个应助lmd采纳,获得10
11秒前
14秒前
讨厌组会发布了新的文献求助20
15秒前
YZT8848完成签到,获得积分10
16秒前
19秒前
无花果应助ikun采纳,获得10
24秒前
共享精神应助鲜艳的沛文采纳,获得10
25秒前
852应助LY采纳,获得10
29秒前
阿德利企鹅完成签到,获得积分10
30秒前
鲜艳的沛文完成签到,获得积分20
31秒前
32秒前
35秒前
35秒前
搜集达人应助naturehome采纳,获得10
36秒前
kiki134发布了新的文献求助10
37秒前
37秒前
未命名发布了新的文献求助10
41秒前
chen完成签到 ,获得积分10
42秒前
无花果应助哈哈哈采纳,获得10
43秒前
JZY发布了新的文献求助10
43秒前
112完成签到,获得积分20
44秒前
44秒前
44秒前
46秒前
llwei发布了新的文献求助10
47秒前
naturehome发布了新的文献求助10
48秒前
112发布了新的文献求助10
48秒前
ANIJA完成签到,获得积分10
49秒前
49秒前
CodeCraft应助优雅的夜柳采纳,获得10
51秒前
LY发布了新的文献求助10
51秒前
JZY完成签到,获得积分10
51秒前
ikun发布了新的文献求助10
52秒前
咳咳关注了科研通微信公众号
53秒前
NagatoYuki完成签到,获得积分10
55秒前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
[Lambert-Eaton syndrome without calcium channel autoantibodies] 520
Pressing the Fight: Print, Propaganda, and the Cold War 500
Bernd Ziesemer - Maos deutscher Topagent: Wie China die Bundesrepublik eroberte 500
The Three Stars Each: The Astrolabes and Related Texts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2470685
求助须知:如何正确求助?哪些是违规求助? 2137471
关于积分的说明 5446445
捐赠科研通 1861584
什么是DOI,文献DOI怎么找? 925807
版权声明 562721
科研通“疑难数据库(出版商)”最低求助积分说明 495235